Cargando…
Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni
BACKGROUND: World Health Organization (WHO) guidelines for measuring global progress in schistosomiasis control classify individuals with Schistosoma spp. infections based on the concentration of excreted eggs. We assessed the associations between WHO infection intensity categories and morbidity pre...
Autores principales: | Wiegand, Ryan E., Secor, W. Evan, Fleming, Fiona M., French, Michael D., King, Charles H., Deol, Arminder K., Montgomery, Susan P., Evans, Darin, Utzinger, Jürg, Vounatsou, Penelope, de Vlas, Sake J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183985/ https://www.ncbi.nlm.nih.gov/pubmed/34033646 http://dx.doi.org/10.1371/journal.pntd.0009444 |
Ejemplares similares
-
Modelling age-heterogeneous Schistosoma haematobium and S. mansoni survey data via alignment factors
por: Schur, Nadine, et al.
Publicado: (2011) -
Bayesian Risk Mapping and Model-Based Estimation of Schistosoma haematobium–Schistosoma mansoni Co-distribution in Côte d′Ivoire
por: Chammartin, Frédérique, et al.
Publicado: (2014) -
Urogenital schistosomiasis infection prevalence targets to determine elimination as a public health problem based on microhematuria prevalence in school-age children
por: Wiegand, Ryan E., et al.
Publicado: (2021) -
SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection
por: King, Charles H., et al.
Publicado: (2020) -
Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa
por: King, Charles H., et al.
Publicado: (2020)